|Bid||8.70 x 3000|
|Ask||9.07 x 1300|
|Day's range||8.61 - 9.39|
|52-week range||8.60 - 22.40|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||22 Feb 2022 - 28 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||31.50|
Heron Therapeutics (HRTX) delivered earnings and revenue surprises of 15.00% and -7.23%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
These once-promising biotech stocks are trading at a fraction of their all-time highs right now.
One thing we could say about the analysts on Heron Therapeutics, Inc. ( NASDAQ:HRTX ) - they aren't optimistic, having...